UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                   FORM 12b-25

                           NOTIFICATION OF LATE FILING

(Check One):    |X| Form 10-KSB  |_| Form 20-F   |_| Form 11-K  |_| Form 10-QSB
                |_| Form 10-D    |_| Form N-SAR  |_| Form N-CSR


                For Period Ended: December 31, 2005

                |_| Transition Report on Form 10-K
                |_| Transition Report on  Form 20-F
                |_| Transition Report on Form 11-K
                |_| Transition Report on Form 10-Q
                |_| Transition Report on Form N-SAR For the Transition Period
                    Ended:

- --------------------------------------------------------------------------------
  Read Instruction (on back page) Before Preparing Form. Please Print or Type.
    Nothing in this form shall be construed to imply that the Commission has
                   verified any information contained herein.
- --------------------------------------------------------------------------------


If the notification  relates to a portion of the filing checked above,  identify
the item(s) to which the notification relates:
- --------------------------------------------------------------------------------

                         PART I - REGISTRANT INFORMATION

                                Concentrax, Inc.
                                ----------------
                             Full name of Registrant

                                       N/A
                                       ---
                            Former Name if Applicable

                          2400 Augusta Place, Ste. 425
                          ----------------------------
            Address of Principal Executive Office (Street and Number)

                              Houston, Texas 77057
                              --------------------
                            City, State and Zip Code

                        PART II - RULE 12b-25(b) AND (c)

If the subject report could not be filed without unreasonable effort or expense
and the registrant seeks relief pursuant to Rule 12b-25(b), the following should
be completed. (Check box if appropriate.)

     | (a)  The reasons  described  in  reasonable  detail  in Part III  of this
     |      form could not be eliminated without unreasonable effort or expense;
     | (b)  The subject annual report, semi-annual report, transition report on
     |      Form 10-K,  Form 20-F,  Form 11-K,  Form N-SAR,  or Form  N-CSR,  or
     |      portion thereof,  will be filed on or before the fifteenth  calendar
 |X| |      day  following  the prescribed  due date;  or the subject  quarterly
     |      report or transition report on Form 10-Q, or portion thereof will be
     |      filed on or before the fifth calendar day following  the  prescribed
     |      due date; and
     | (c)  The  accountant's  statement  or other  exhibit  required by Rule
     |      12b-25(c) has been attached if applicable.



                              PART III - NARRATIVE

State below in reasonable  detail the reasons why Forms 10-K,  20-F, 11-K, 10-Q,
10-D, N-SAR,  N-CSR, or the transition  report or portion thereof,  could not be
filed within the prescribed time period.
(Attach extra sheets if needed.)

     The compilation, dissemination and review of the information required to be
presented  in  the  Form  10-KSB  for  the  relevant  period  has  imposed  time
constraints  that have rendered  timely filing of the Form 10-KSB  impracticable
without undue hardship and expense to the registrant.

                           PART IV - OTHER INFORMATION

     (1) Name and  telephone  number  of  person  to  contact  in regard to this
         notification

                Robert D. Francis         (727)             593-1220
                -----------------         -----             --------
                    (Name)            (Area Code)       (Telephone Number)

     (2)  Have all other periodic  reports required under Section 13 or 15(d) of
          the  Securities  Exchange Act of 1934 or Section 30 of the  Investment
          Company Act of 1940 during the preceding 12 months or for such shorter
          period that the  registrant  was required to file such  report(s) been
          filed? If the answer is no, identify report(s). Yes |_| No |X|

          The  registrant  has not filed its Forms 10-QSB for the periods  ended
          June 30, 2004,  September 30, 2004,  March 31, 2005, June 30, 2005 and
          September 30, 2005. In addition, the registrant has not filed its Form
          10-KSB for the fiscal year ended December 31, 2004.

     (3)  Is it anticipated that any significant change in results of operations
          from  the  corresponding  period  for the  last  fiscal  year  will be
          reflected  by the  earnings  statements  to be included in the subject
          report or portion thereof? Yes |_| No |X|

          If  so:  attach  an  explanation  of  the  anticipated   change,  both
          narratively and quantitatively, and, if appropriate, state the reasons
          why a reasonable estimate of the results cannot be made.

- --------------------------------------------------------------------------------




                                Concentrax, Inc.
                                ----------------
                  (Name of Registrant as Specified in Charter)

Has  caused  this  notification  to be signed on its  behalf by the  undersigned
thereunto duly authorized.

Date: March 21, 2006                      By: /s/ Robert D. Francis
      --------------                      ---------------------------
                                          Name: Robert D. Francis
                                          Title: Chief Executive Officer


INSTRUCTION: The form may be signed by an executive officer of the registrant or
by any other duly  authorized  representative.  The name and title of the person
signing  the form  shall  be typed or  printed  beneath  the  signature.  If the
statement is signed on behalf of the registrant by an authorized  representative
(other than an executive officer), evidence of the representative's authority to
sign on behalf of the registrant shall be filed with the form.